114.09 0.00 (0.00%)
After hours: 5:42PM EST
|Bid||0.00 x 1400|
|Ask||0.00 x 800|
|Day's Range||111.02 - 114.65|
|52 Week Range||73.69 - 119.84|
|Beta (3Y Monthly)||0.64|
|PE Ratio (TTM)||262.28|
|Earnings Date||Feb 13, 2019|
|Forward Dividend & Yield||2.25 (1.98%)|
|1y Target Est||114.06|
The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company
Costco stock and Okta stock lead five top stocks to watch. Investors shouldn't be making new buys, but these stocks could break out once conditions improve.
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) […]
U.S. equities have suffered from another bout of harrowing volatility this week as investors scramble to survive this bear market. The Dow Jones Industrial Average is threatening to fall below its multi-month support level to return to lows not seen since the beginning of the year. If those February lows are violated, watch for a possible reversal of much of the 2017 Trump tax cut rally.
Health-care stocks have found new life as markets crater. UnitedHealth UNH and Eli Lilly LLY roared to record highs on Tuesday, while Pfizer PFE and Merck MRK moved to their highest levels since 2001, although they were all down at least 1 percent in Thursday's premarket. Mark Newton , technical analyst at Newton Advisors, said Tuesday the overall health-care trade still looks like a solid play.
NEW YORK, NY / ACCESSWIRE / December 5, 2018 / U.S. equities plunged on Tuesday as skepticism over the U.S. and China’s ability to close a trade agreement weighed on the markets. The Dow Jones Industrial ...
How Is Teva Pharmaceutical Positioned in 2018? On September 14, Teva Pharmaceutical (TEVA) issued a press release announcing FDA approval of Ajovy, a humanized monoclonal antibody and anti-calcitonin gene-related peptide (or CGRP) therapy for migraine prevention indication. Teva Pharmaceutical expects to secure regulatory approval from the European Commission (or EC) for Ajovy in migraine prevention indication in H1 2019.
With the announced sale of its animal health division, Bayer became the latest pharmaceutical company to reverse this decade-long M&A binge.
Project to focus on preclinical and clinical research with cyclin dependent kinase (CDK)4 & 6 inhibitors PLYMOUTH MEETING, Pa. and INDIANAPOLIS , Dec. 3, 2018 /PRNewswire/ -- The National Comprehensive ...
NEW YORK, Dec. 03, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
With Fed Chairman Powell sounding a more dovish tone, U.S. interest rates are likely to increase at a slower rate than previously anticipated. This shift will benefit companies that earn a significant portion of their revenues outside the U.S., like the big pharma names mentioned above.
Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Alkermes, one of the state’s largest drugmakers, announced the results of a late-stage trial of a schizophrenia drug Thursday it calls "positive," but doubts emerged about the drug’s effect on patients’ weight.
The large-cap pharma industry has been on a strong footing lately. Here are four stocks from the space that investors may consider betting on.